The Global Mediastinal Mass Treatment market growth is fueled by the increasing prevalence of thymomas, lymphomas, germ cell tumors, and metastatic cancers affecting the mediastinum. The adoption of advanced imaging tools, including PET, CT, and MRI, has significantly improved tumor detection and staging, enabling earlier diagnosis and enhanced patient survival. The integration of precision oncology and immunotherapy has transformed conventional cancer care, offering tailored...